← All trials
NCT07115368
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 11, 2025
- Primary completion
- Sep 19, 2025
- Completion date
- Oct 2, 2025
- First posted
- Aug 11, 2025
- Last posted
- Oct 21, 2025
- Enrollment
- 4
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Gilead SciencesLead sponsor
- Gilead SciencesOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.